International drug companies are threatening to remove medicines from the market if Australia doesn’t offer them a better price. Here’s what’s at stake.
- Associate Lecturer, School of Pharmacy and Charles Perkins Centre, University of Sydney
Australia is still aiming to start vaccinating high-risk groups from March. Why the delay?
A private market should have no place in the rollout of a COVID vaccine.


